Protagonist Therapeutics, Inc (PTGX) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2013: -$1.39M2014: -$12.62M2015: -$27.40M2016: $87.56M2017: $120.63M2018: $112.52M2019: $79.96M2020: $279.61M2021: $300.02M2022: $215.61M2023: $336.68M2024: $675.29M2025: $614.71M$614.71M
2013Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$614.71M-9.0%
2024$675.29M+100.6%
2023$336.68M+56.2%
2022$215.61M-28.1%
2021$300.02M+7.3%
2020$279.61M+249.7%
2019$79.96M-28.9%
2018$112.52M-6.7%
2017$120.63M+37.8%
2016$87.56M+419.5%
2015-$27.40M-117.1%
2014-$12.62M-805.4%
2013-$1.39M